44
Participants
Start Date
January 24, 2022
Primary Completion Date
October 24, 2023
Study Completion Date
October 24, 2024
Lamotrigine
Participants will be randomized to lamotrigine (25 mg/day to 200 mg/day in two divided doses) for 9 weeks. A comparator group will receive placebo (sugar pills).
Placebo
Matching placebo (sugar pill)
Brown University Center for Alcohol and Addiction Studies, Providence
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Rhode Island Hospital
OTHER
Brown University
OTHER